-
-
-
-
-
-
-
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
-
-
-
-
-
-
-
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
-
-
-
-
-
-
-
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth
-
-
-
-
-
-
-
QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions
-
-
-
-
-
-
-
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels
-
-
-
-
-
-
-
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software
-
-
-
-
-
-
-
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025
-
1,209,936 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

